Leveraging Post-marketing Drug Safety Research through Semantic Technologies: The PharmacoVigilance Signal Detectors Ontology.

作者: Marie-Christine Jaulent , Vassilis Koutkias

DOI:

关键词:

摘要: Accurate and timely identification of post-marketing drug safety risks (the so-called “signals” in pharmacovigilance) is an important public health issue. While various computational methods have been proposed to analyze the diverse data sources employed for signal detection, still challenge effective monitoring surveillance remains. On other hand, there emerging belief that synthesis all possible information necessary achieve further advancements. Aiming facilitate integrated detection by concurrently exploring via respective analysis a systematic way, we propose PharmacoVigilance Signal Detectors Ontology (PV-SDO). PV-SDO constitutes backbone semantically-enriched platform this integration aims to: (a) semantically harmonize heterogeneous field, (b) their joint exploitation through mappings between reference terminologies rely on, (c) provide exploitable knowledge base methods, experiments outcomes including provenance information. has populated with significant number individuals using from open-source method implementations, assessed data-driven logicbased techniques, while evaluation experts currently being conducted well-promising results.

参考文章(21)
Ola Caster, Kristina Juhlin, Sarah Watson, G. Niklas Norén, Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank Drug Safety. ,vol. 37, pp. 617- 628 ,(2014) , 10.1007/S40264-014-0204-5
Luc Moreau, Paul Groth, PROV-Overview. An Overview of the PROV Family of Documents World Wide Web Consortium. ,(2013)
Preventing Medication Errors, Philip Aspden, Preventing Medication Errors ,(2007)
Janez Brank, Marko Grobelnik, Dunja Mladenic, A SURVEY OF ONTOLOGY EVALUATION TECHNIQUES ,(2005)
Marc Suling, Iris Pigeot, Signal Detection and Monitoring Based on Longitudinal Healthcare Data Pharmaceutics. ,vol. 4, pp. 607- 640 ,(2012) , 10.3390/PHARMACEUTICS4040607
Marie Lindquist, The Need for Definitions in Pharmacovigilance Drug Safety. ,vol. 30, pp. 825- 830 ,(2007) , 10.2165/00002018-200730100-00001
Manfred Hauben, G. Niklas Norén, A decade of data mining and still counting Drug Safety. ,vol. 33, pp. 527- 534 ,(2010) , 10.2165/11532430-000000000-00000
Stephen A. Goldman, Limitations and strengths of spontaneous reports data Clinical Therapeutics. ,vol. 20, ,(1998) , 10.1016/S0149-2918(98)80007-6
Rave Harpaz, Alison Callahan, Suzanne Tamang, Yen Low, David Odgers, Sam Finlayson, Kenneth Jung, Paea LePendu, Nigam H Shah, None, Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art Drug Safety. ,vol. 37, pp. 777- 790 ,(2014) , 10.1007/S40264-014-0218-Z